Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Remdesivir Market Growth 2022-2028

  • LP 4822307
  • 97 Pages
  • February 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Remdesivir will have significant change from previous year. According to our (LP Information) latest study, the global Remdesivir market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Remdesivir market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Remdesivir market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Remdesivir market, reaching US$ million by the year 2028. As for the Europe Remdesivir landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Remdesivir players cover Gilead Sciences, Bright Gene, Hainan Haiyao, and Kelun Pharma, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Remdesivir market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

10 mM*1 mL in DMSO

5mg

10mg

50mg

100mg

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Hospital

Clinics

Drug Store

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Gilead Sciences

Bright Gene

Hainan Haiyao

Kelun Pharma

Hunan Warrant Pharmaceutical

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Remdesivir Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Remdesivir by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Remdesivir by Country/Region, 2017, 2022 & 2028

2.2 Remdesivir Segment by Type

2.2.1 10 mM*1 mL in DMSO

2.2.2 5mg

2.2.3 10mg

2.2.4 50mg

2.2.5 100mg

2.3 Remdesivir Sales by Type

2.3.1 Global Remdesivir Sales Market Share by Type (2017-2022)

2.3.2 Global Remdesivir Revenue and Market Share by Type (2017-2022)

2.3.3 Global Remdesivir Sale Price by Type (2017-2022)

2.4 Remdesivir Segment by Application

2.4.1 Hospital

2.4.2 Clinics

2.4.3 Drug Store

2.4.4 Others

2.5 Remdesivir Sales by Application

2.5.1 Global Remdesivir Sale Market Share by Application (2017-2022)

2.5.2 Global Remdesivir Revenue and Market Share by Application (2017-2022)

2.5.3 Global Remdesivir Sale Price by Application (2017-2022)

3 Global Remdesivir by Company

3.1 Global Remdesivir Breakdown Data by Company

3.1.1 Global Remdesivir Annual Sales by Company (2020-2022)

3.1.2 Global Remdesivir Sales Market Share by Company (2020-2022)

3.2 Global Remdesivir Annual Revenue by Company (2020-2022)

3.2.1 Global Remdesivir Revenue by Company (2020-2022)

3.2.2 Global Remdesivir Revenue Market Share by Company (2020-2022)

3.3 Global Remdesivir Sale Price by Company

3.4 Key Manufacturers Remdesivir Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Remdesivir Product Location Distribution

3.4.2 Players Remdesivir Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Remdesivir by Geographic Region

4.1 World Historic Remdesivir Market Size by Geographic Region (2017-2022)

4.1.1 Global Remdesivir Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Remdesivir Annual Revenue by Geographic Region

4.2 World Historic Remdesivir Market Size by Country/Region (2017-2022)

4.2.1 Global Remdesivir Annual Sales by Country/Region (2017-2022)

4.2.2 Global Remdesivir Annual Revenue by Country/Region

4.3 Americas Remdesivir Sales Growth

4.4 APAC Remdesivir Sales Growth

4.5 Europe Remdesivir Sales Growth

4.6 Middle East & Africa Remdesivir Sales Growth

5 Americas

5.1 Americas Remdesivir Sales by Country

5.1.1 Americas Remdesivir Sales by Country (2017-2022)

5.1.2 Americas Remdesivir Revenue by Country (2017-2022)

5.2 Americas Remdesivir Sales by Type

5.3 Americas Remdesivir Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Remdesivir Sales by Region

6.1.1 APAC Remdesivir Sales by Region (2017-2022)

6.1.2 APAC Remdesivir Revenue by Region (2017-2022)

6.2 APAC Remdesivir Sales by Type

6.3 APAC Remdesivir Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Remdesivir by Country

7.1.1 Europe Remdesivir Sales by Country (2017-2022)

7.1.2 Europe Remdesivir Revenue by Country (2017-2022)

7.2 Europe Remdesivir Sales by Type

7.3 Europe Remdesivir Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Remdesivir by Country

8.1.1 Middle East & Africa Remdesivir Sales by Country (2017-2022)

8.1.2 Middle East & Africa Remdesivir Revenue by Country (2017-2022)

8.2 Middle East & Africa Remdesivir Sales by Type

8.3 Middle East & Africa Remdesivir Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Remdesivir

10.3 Manufacturing Process Analysis of Remdesivir

10.4 Industry Chain Structure of Remdesivir

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Remdesivir Distributors

11.3 Remdesivir Customer

12 World Forecast Review for Remdesivir by Geographic Region

12.1 Global Remdesivir Market Size Forecast by Region

12.1.1 Global Remdesivir Forecast by Region (2023-2028)

12.1.2 Global Remdesivir Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Remdesivir Forecast by Type

12.7 Global Remdesivir Forecast by Application

13 Key Players Analysis

13.1 Gilead Sciences

13.1.1 Gilead Sciences Company Information

13.1.2 Gilead Sciences Remdesivir Product Offered

13.1.3 Gilead Sciences Remdesivir Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Gilead Sciences Main Business Overview

13.1.5 Gilead Sciences Latest Developments

13.2 Bright Gene

13.2.1 Bright Gene Company Information

13.2.2 Bright Gene Remdesivir Product Offered

13.2.3 Bright Gene Remdesivir Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Bright Gene Main Business Overview

13.2.5 Bright Gene Latest Developments

13.3 Hainan Haiyao

13.3.1 Hainan Haiyao Company Information

13.3.2 Hainan Haiyao Remdesivir Product Offered

13.3.3 Hainan Haiyao Remdesivir Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Hainan Haiyao Main Business Overview

13.3.5 Hainan Haiyao Latest Developments

13.4 Kelun Pharma

13.4.1 Kelun Pharma Company Information

13.4.2 Kelun Pharma Remdesivir Product Offered

13.4.3 Kelun Pharma Remdesivir Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Kelun Pharma Main Business Overview

13.4.5 Kelun Pharma Latest Developments

13.5 Hunan Warrant Pharmaceutical

13.5.1 Hunan Warrant Pharmaceutical Company Information

13.5.2 Hunan Warrant Pharmaceutical Remdesivir Product Offered

13.5.3 Hunan Warrant Pharmaceutical Remdesivir Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Hunan Warrant Pharmaceutical Main Business Overview

13.5.5 Hunan Warrant Pharmaceutical Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Remdesivir Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Remdesivir Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of 10 mM*1 mL in DMSO

Table 4. Major Players of 5mg

Table 5. Major Players of 10mg

Table 6. Major Players of 50mg

Table 7. Major Players of 100mg

Table 8. Global Remdesivir Sales by Type (2017-2022) & (K Units)

Table 9. Global Remdesivir Sales Market Share by Type (2017-2022)

Table 10. Global Remdesivir Revenue by Type (2017-2022) & ($ million)

Table 11. Global Remdesivir Revenue Market Share by Type (2017-2022)

Table 12. Global Remdesivir Sale Price by Type (2017-2022) & (US$/Unit)

Table 13. Global Remdesivir Sales by Application (2017-2022) & (K Units)

Table 14. Global Remdesivir Sales Market Share by Application (2017-2022)

Table 15. Global Remdesivir Revenue by Application (2017-2022)

Table 16. Global Remdesivir Revenue Market Share by Application (2017-2022)

Table 17. Global Remdesivir Sale Price by Application (2017-2022) & (US$/Unit)

Table 18. Global Remdesivir Sales by Company (2020-2022) & (K Units)

Table 19. Global Remdesivir Sales Market Share by Company (2020-2022)

Table 20. Global Remdesivir Revenue by Company (2020-2022) ($ Millions)

Table 21. Global Remdesivir Revenue Market Share by Company (2020-2022)

Table 22. Global Remdesivir Sale Price by Company (2020-2022) & (US$/Unit)

Table 23. Key Manufacturers Remdesivir Producing Area Distribution and Sales Area

Table 24. Players Remdesivir Products Offered

Table 25. Remdesivir Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 26. New Products and Potential Entrants

Table 27. Mergers & Acquisitions, Expansion

Table 28. Global Remdesivir Sales by Geographic Region (2017-2022) & (K Units)

Table 29. Global Remdesivir Sales Market Share Geographic Region (2017-2022)

Table 30. Global Remdesivir Revenue by Geographic Region (2017-2022) & ($ millions)

Table 31. Global Remdesivir Revenue Market Share by Geographic Region (2017-2022)

Table 32. Global Remdesivir Sales by Country/Region (2017-2022) & (K Units)

Table 33. Global Remdesivir Sales Market Share by Country/Region (2017-2022)

Table 34. Global Remdesivir Revenue by Country/Region (2017-2022) & ($ millions)

Table 35. Global Remdesivir Revenue Market Share by Country/Region (2017-2022)

Table 36. Americas Remdesivir Sales by Country (2017-2022) & (K Units)

Table 37. Americas Remdesivir Sales Market Share by Country (2017-2022)

Table 38. Americas Remdesivir Revenue by Country (2017-2022) & ($ Millions)

Table 39. Americas Remdesivir Revenue Market Share by Country (2017-2022)

Table 40. Americas Remdesivir Sales by Type (2017-2022) & (K Units)

Table 41. Americas Remdesivir Sales Market Share by Type (2017-2022)

Table 42. Americas Remdesivir Sales by Application (2017-2022) & (K Units)

Table 43. Americas Remdesivir Sales Market Share by Application (2017-2022)

Table 44. APAC Remdesivir Sales by Region (2017-2022) & (K Units)

Table 45. APAC Remdesivir Sales Market Share by Region (2017-2022)

Table 46. APAC Remdesivir Revenue by Region (2017-2022) & ($ Millions)

Table 47. APAC Remdesivir Revenue Market Share by Region (2017-2022)

Table 48. APAC Remdesivir Sales by Type (2017-2022) & (K Units)

Table 49. APAC Remdesivir Sales Market Share by Type (2017-2022)

Table 50. APAC Remdesivir Sales by Application (2017-2022) & (K Units)

Table 51. APAC Remdesivir Sales Market Share by Application (2017-2022)

Table 52. Europe Remdesivir Sales by Country (2017-2022) & (K Units)

Table 53. Europe Remdesivir Sales Market Share by Country (2017-2022)

Table 54. Europe Remdesivir Revenue by Country (2017-2022) & ($ Millions)

Table 55. Europe Remdesivir Revenue Market Share by Country (2017-2022)

Table 56. Europe Remdesivir Sales by Type (2017-2022) & (K Units)

Table 57. Europe Remdesivir Sales Market Share by Type (2017-2022)

Table 58. Europe Remdesivir Sales by Application (2017-2022) & (K Units)

Table 59. Europe Remdesivir Sales Market Share by Application (2017-2022)

Table 60. Middle East & Africa Remdesivir Sales by Country (2017-2022) & (K Units)

Table 61. Middle East & Africa Remdesivir Sales Market Share by Country (2017-2022)

Table 62. Middle East & Africa Remdesivir Revenue by Country (2017-2022) & ($ Millions)

Table 63. Middle East & Africa Remdesivir Revenue Market Share by Country (2017-2022)

Table 64. Middle East & Africa Remdesivir Sales by Type (2017-2022) & (K Units)

Table 65. Middle East & Africa Remdesivir Sales Market Share by Type (2017-2022)

Table 66. Middle East & Africa Remdesivir Sales by Application (2017-2022) & (K Units)

Table 67. Middle East & Africa Remdesivir Sales Market Share by Application (2017-2022)

Table 68. Key Market Drivers & Growth Opportunities of Remdesivir

Table 69. Key Market Challenges & Risks of Remdesivir

Table 70. Key Industry Trends of Remdesivir

Table 71. Remdesivir Raw Material

Table 72. Key Suppliers of Raw Materials

Table 73. Remdesivir Distributors List

Table 74. Remdesivir Customer List

Table 75. Global Remdesivir Sales Forecast by Region (2023-2028) & (K Units)

Table 76. Global Remdesivir Sales Market Forecast by Region

Table 77. Global Remdesivir Revenue Forecast by Region (2023-2028) & ($ millions)

Table 78. Global Remdesivir Revenue Market Share Forecast by Region (2023-2028)

Table 79. Americas Remdesivir Sales Forecast by Country (2023-2028) & (K Units)

Table 80. Americas Remdesivir Revenue Forecast by Country (2023-2028) & ($ millions)

Table 81. APAC Remdesivir Sales Forecast by Region (2023-2028) & (K Units)

Table 82. APAC Remdesivir Revenue Forecast by Region (2023-2028) & ($ millions)

Table 83. Europe Remdesivir Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Europe Remdesivir Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Middle East & Africa Remdesivir Sales Forecast by Country (2023-2028) & (K Units)

Table 86. Middle East & Africa Remdesivir Revenue Forecast by Country (2023-2028) & ($ millions)

Table 87. Global Remdesivir Sales Forecast by Type (2023-2028) & (K Units)

Table 88. Global Remdesivir Sales Market Share Forecast by Type (2023-2028)

Table 89. Global Remdesivir Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 90. Global Remdesivir Revenue Market Share Forecast by Type (2023-2028)

Table 91. Global Remdesivir Sales Forecast by Application (2023-2028) & (K Units)

Table 92. Global Remdesivir Sales Market Share Forecast by Application (2023-2028)

Table 93. Global Remdesivir Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 94. Global Remdesivir Revenue Market Share Forecast by Application (2023-2028)

Table 95. Gilead Sciences Basic Information, Remdesivir Manufacturing Base, Sales Area and Its Competitors

Table 96. Gilead Sciences Remdesivir Product Offered

Table 97. Gilead Sciences Remdesivir Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 98. Gilead Sciences Main Business

Table 99. Gilead Sciences Latest Developments

Table 100. Bright Gene Basic Information, Remdesivir Manufacturing Base, Sales Area and Its Competitors

Table 101. Bright Gene Remdesivir Product Offered

Table 102. Bright Gene Remdesivir Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 103. Bright Gene Main Business

Table 104. Bright Gene Latest Developments

Table 105. Hainan Haiyao Basic Information, Remdesivir Manufacturing Base, Sales Area and Its Competitors

Table 106. Hainan Haiyao Remdesivir Product Offered

Table 107. Hainan Haiyao Remdesivir Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 108. Hainan Haiyao Main Business

Table 109. Hainan Haiyao Latest Developments

Table 110. Kelun Pharma Basic Information, Remdesivir Manufacturing Base, Sales Area and Its Competitors

Table 111. Kelun Pharma Remdesivir Product Offered

Table 112. Kelun Pharma Remdesivir Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 113. Kelun Pharma Main Business

Table 114. Kelun Pharma Latest Developments

Table 115. Hunan Warrant Pharmaceutical Basic Information, Remdesivir Manufacturing Base, Sales Area and Its Competitors

Table 116. Hunan Warrant Pharmaceutical Remdesivir Product Offered

Table 117. Hunan Warrant Pharmaceutical Remdesivir Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 118. Hunan Warrant Pharmaceutical Main Business

Table 119. Hunan Warrant Pharmaceutical Latest Developments

List of Figures

Figure 1. Picture of Remdesivir

Figure 2. Remdesivir Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Remdesivir Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Remdesivir Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Remdesivir Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of 10 mM*1 mL in DMSO

Figure 10. Product Picture of 5mg

Figure 11. Product Picture of 10mg

Figure 12. Product Picture of 50mg

Figure 13. Product Picture of 100mg

Figure 14. Global Remdesivir Sales Market Share by Type in 2021

Figure 15. Global Remdesivir Revenue Market Share by Type (2017-2022)

Figure 16. Remdesivir Consumed in Hospital

Figure 17. Global Remdesivir Market: Hospital (2017-2022) & (K Units)

Figure 18. Remdesivir Consumed in Clinics

Figure 19. Global Remdesivir Market: Clinics (2017-2022) & (K Units)

Figure 20. Remdesivir Consumed in Drug Store

Figure 21. Global Remdesivir Market: Drug Store (2017-2022) & (K Units)

Figure 22. Remdesivir Consumed in Others

Figure 23. Global Remdesivir Market: Others (2017-2022) & (K Units)

Figure 24. Global Remdesivir Sales Market Share by Application (2017-2022)

Figure 25. Global Remdesivir Revenue Market Share by Application in 2021

Figure 26. Remdesivir Revenue Market by Company in 2021 ($ Million)

Figure 27. Global Remdesivir Revenue Market Share by Company in 2021

Figure 28. Global Remdesivir Sales Market Share by Geographic Region (2017-2022)

Figure 29. Global Remdesivir Revenue Market Share by Geographic Region in 2021

Figure 30. Global Remdesivir Sales Market Share by Region (2017-2022)

Figure 31. Global Remdesivir Revenue Market Share by Country/Region in 2021

Figure 32. Americas Remdesivir Sales 2017-2022 (K Units)

Figure 33. Americas Remdesivir Revenue 2017-2022 ($ Millions)

Figure 34. APAC Remdesivir Sales 2017-2022 (K Units)

Figure 35. APAC Remdesivir Revenue 2017-2022 ($ Millions)

Figure 36. Europe Remdesivir Sales 2017-2022 (K Units)

Figure 37. Europe Remdesivir Revenue 2017-2022 ($ Millions)

Figure 38. Middle East & Africa Remdesivir Sales 2017-2022 (K Units)

Figure 39. Middle East & Africa Remdesivir Revenue 2017-2022 ($ Millions)

Figure 40. Americas Remdesivir Sales Market Share by Country in 2021

Figure 41. Americas Remdesivir Revenue Market Share by Country in 2021

Figure 42. United States Remdesivir Revenue Growth 2017-2022 ($ Millions)

Figure 43. Canada Remdesivir Revenue Growth 2017-2022 ($ Millions)

Figure 44. Mexico Remdesivir Revenue Growth 2017-2022 ($ Millions)

Figure 45. Brazil Remdesivir Revenue Growth 2017-2022 ($ Millions)

Figure 46. APAC Remdesivir Sales Market Share by Region in 2021

Figure 47. APAC Remdesivir Revenue Market Share by Regions in 2021

Figure 48. China Remdesivir Revenue Growth 2017-2022 ($ Millions)

Figure 49. Japan Remdesivir Revenue Growth 2017-2022 ($ Millions)

Figure 50. South Korea Remdesivir Revenue Growth 2017-2022 ($ Millions)

Figure 51. Southeast Asia Remdesivir Revenue Growth 2017-2022 ($ Millions)

Figure 52. India Remdesivir Revenue Growth 2017-2022 ($ Millions)

Figure 53. Australia Remdesivir Revenue Growth 2017-2022 ($ Millions)

Figure 54. Europe Remdesivir Sales Market Share by Country in 2021

Figure 55. Europe Remdesivir Revenue Market Share by Country in 2021

Figure 56. Germany Remdesivir Revenue Growth 2017-2022 ($ Millions)

Figure 57. France Remdesivir Revenue Growth 2017-2022 ($ Millions)

Figure 58. UK Remdesivir Revenue Growth 2017-2022 ($ Millions)

Figure 59. Italy Remdesivir Revenue Growth 2017-2022 ($ Millions)

Figure 60. Russia Remdesivir Revenue Growth 2017-2022 ($ Millions)

Figure 61. Middle East & Africa Remdesivir Sales Market Share by Country in 2021

Figure 62. Middle East & Africa Remdesivir Revenue Market Share by Country in 2021

Figure 63. Egypt Remdesivir Revenue Growth 2017-2022 ($ Millions)

Figure 64. South Africa Remdesivir Revenue Growth 2017-2022 ($ Millions)

Figure 65. Israel Remdesivir Revenue Growth 2017-2022 ($ Millions)

Figure 66. Turkey Remdesivir Revenue Growth 2017-2022 ($ Millions)

Figure 67. GCC Country Remdesivir Revenue Growth 2017-2022 ($ Millions)

Figure 68. Manufacturing Cost Structure Analysis of Remdesivir in 2021

Figure 69. Manufacturing Process Analysis of Remdesivir

Figure 70. Industry Chain Structure of Remdesivir

Figure 71. Channels of Distribution

Figure 72. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390